GlobalData on MSN
Acesion begins patient enrolment in AP31969 Phase II AF study
The trial’s primary efficacy endpoint is AF burden, which refers to the percentage of time a participant is in AF.
Acesion Pharma ("Acesion" or "the Company"), a biotech company pioneering treatments for atrial fibrillation ("AF"), the most common cardiac arrhythmia, today announces enrolment of the first patients ...
Please provide your email address to receive an email when new articles are posted on . Implicity announced the FDA cleared its algorithm analyzing ECG data from implantable loop recorders.
Please provide your email address to receive an email when new articles are posted on . An artificial intelligence-based ECG analysis solution reduced the rate of false-positive atrial fibrillation ...
(MENAFN- GetNews) According to a recent report published by Grand View Research Inc., the growing incidence of cardiac disorders in the geriatric population and high demand for advanced medical ...
The Reveal in the Investigation of Syncope and Epilepsy (REVISE) study found that one in eight patients who were previously thought to have epilepsy or in whom this diagnosis was in doubt actually had ...
Dublin, Jan. 17, 2025 (GLOBE NEWSWIRE) -- The "Implantable Loop Recorders Market Size, Share & Trends Analysis Report By Activation, By Application, By End Use, By Region, And Segment Forecasts, 2025 ...
62-yr- old Bangladeshi receives first implantable loop recorder in Maharashtra to track his ECG 24*7
For the first time in Maharashtra, Nanavati Super Speciality Hospital has inserted implantable loop recorder in a 62-year-old patient from Bangladesh suffering from syncope to track his heart rhythm ...
Barcelona, Spain, 1 September 2009: The REVISE Study (Reveal in the Investigation of Syncope and Epilepsy) found that 1 in 8 adult patients in the United Kingdom, previously thought to be suffering ...
Dublin, Dec. 18, 2017 (GLOBE NEWSWIRE) -- The "Cardiovascular Disease Monitoring and Diagnostic Devices - Global Strategic Business Report" report has been added to Research and Markets' offering. The ...
Dublin, Aug. 26, 2020 (GLOBE NEWSWIRE) -- The "Global Implantable Loop Recorders Market By Application (Atrial fibrillation, Cardiac Arrhythmia and Cardiac syncope), By End User (Hospitals, Cardiac ...
According to HTF market Intelligence, the global Implantable Cardiac Loop Recorders market is estimated to grow with a CAGR of 9.19% from 2024 to 2030. Stay up-to-date with Global Implantable Cardiac ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results